ConforMIS, Inc., has announced it has expanded its Series E round financing to $167.7 million.

ConforMIS, based in Bedford, Mass., is a privately held medical device company focusing on orthopedic implants and instrumentation.

The funding included participation from sovereign wealth funds, government investment funds and PE funds in the U.S., Europe, Asia and the Middle East.

ConforMIS said it intends to use the funds to expand commercialization of its iTotal G2 total knee replacement system.